Viatris VTRS
NASDAQ VTRS
$16.44 -0.17 (-0.99%)
As of: Sep 9, 2026 · 3:06 PM EDT

Viatris (VTRS) Total Debt (2019 - 2026)

Viatris (VTRS) posted Total Debt of $13.4 billion for Q2 2026, down 6.92% on a QoQ basis from $14.3 billion in Q1 2026, and down 7.75% year-over-year from $14.5 billion in Q2 2025.

Analysis

Viatris (VTRS) Total Debt (2019 - 2026) Analysis & Trends

Viatris has reported Total Debt for 8 years, with the latest figure at $13.4 billion in Q2 2026.

  • On a quarterly basis, Total Debt fell 7.75% year-over-year to $13.4 billion in Q2 2026; TTM through Jun 2026 was $13.4 billion, a 7.75% decrease from a year earlier, with the FY2025 full-year figure at $14.4 billion, up 2.61% from the prior year.
  • Total Debt was $13.4 billion for Q2 2026 at Viatris, down from $14.3 billion in the prior quarter.
  • The five-year high for Total Debt was $22.0 billion in Q1 2022, with the low at $13.4 billion in Q2 2026.
  • Average Total Debt over 5 years is $17.0 billion, with a median of $17.5 billion recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Total Debt fell 22.53% in 2024, then rose 2.61% in 2025.
  • Over 5 years, Total Debt stood at $19.3 billion in 2022, then decreased by 5.93% to $18.1 billion in 2023, then dropped by 22.53% to $14.0 billion in 2024, then advanced by 2.61% to $14.4 billion in 2025, then declined by 7.37% to $13.4 billion in 2026.
  • The last three Total Debt figures came in at $13.4 billion (Q2 2026), $14.3 billion (Q1 2026), and $14.4 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn 16.59 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 13.35 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 813.33 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn 2.67 Bn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 21.61 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 1.34 Bn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 301.48 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 612.05 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn -
10 RedHill Biopharma 178.79 Mn 178.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.35 Bn
Mar 31, 2026 14.34 Bn
Dec 31, 2025 14.41 Bn
Sep 30, 2025 14.44 Bn
Jun 30, 2025 14.47 Bn
Mar 31, 2025 14.19 Bn
Dec 31, 2024 14.05 Bn
Sep 30, 2024 15.75 Bn
Jun 30, 2024 17.10 Bn
Mar 31, 2024 17.97 Bn
Dec 31, 2023 18.13 Bn
Sep 30, 2023 18.38 Bn
Jun 30, 2023 18.60 Bn
Mar 31, 2023 18.78 Bn
Dec 31, 2022 19.27 Bn
Sep 30, 2022 19.99 Bn
Jun 30, 2022 21.25 Bn
Mar 31, 2022 22.02 Bn
Dec 31, 2021 23.09 Bn
Sep 30, 2021 23.47 Bn